BUND FINANCE

BUND FINANCE › Stocks › SNY

Sanofi (SNY)

NASDAQ · Stock price, chart and technical analysis

US$47.12-0.4100 (-0.86%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$47.53
OpenUS$47.41
Day rangeUS$47.11 – US$47.76
52-week rangeUS$39.07 – US$50.61
Market capUS$113.15B
Volume2.32M
50-day averageUS$42.85
200-day averageUS$44.37
Beta0.28
Last dividend per shareUS$2.42

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueEUR 39.2BEUR 40.6BEUR 41.6BEUR 44.3BEUR 46.7B
Net incomeEUR 6.2BEUR 8.4BEUR 5.4BEUR 5.6BEUR 7.8B
EPS (diluted)2.493.182.152.193.20
Gross margin68.7%70.7%69.7%70.2%72.1%
Operating margin20.7%25.1%16.7%16.4%20.5%
Net margin15.9%20.6%13.0%12.6%16.7%
Free cash flowEUR 8.5BEUR 8.4BEUR 7.4BEUR 5.9BEUR 7.2B
Total debtEUR 22.4BEUR 21.2BEUR 18.7BEUR 17.9BEUR 20.3B
CashEUR 10.1BEUR 12.7BEUR 8.7BEUR 7.4BEUR 7.7B

Compound annual growth: revenue 4.5% · net income 5.9% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E—17.4x27.1x
EV / EBITDA—10.2x16.5x
Operating margin16.3%—3.6%
Net margin8.2%—-0.0%
Debt / equity0.78—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation. The company reports in another currency: amounts are shown in that currency.

About Sanofi

SectorHealthcare
IndustryDrug Manufacturers - General
CountryFR
CEOBelén Garijo López
Employees76,493
IPO date2002-07-01

Sanofi is a global healthcare enterprise dedicated to the research, development, manufacturing, and commercialization of therapeutic solutions across the United States, Europe, and other international markets. Its business is structured into three primary divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. The Pharmaceuticals segment delivers specialized treatments, encompassing human monoclonal antibodies and therapies for a range of conditions such as multiple sclerosis, neurological disorders, various inflammatory and immunological diseases, rare disorders, oncology, and rare blood conditions. This division also provides medications for diabetes, cardiovascular health, and a po…

www.sanofi.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice